Navigation Links
Quit smoking after cancer diagnosis

According to a new study it is observed that motivating people to give up smoking, after a cancer diagnosis, is not necessarily more effective than just ordering them to quit. When someone is diagnosed with cancer,// they may well be more responsive than ever before to the idea of giving up smoking. Researchers at the Royal Adelaide Hospital Cancer Centre, in Melbourne, have been considering at the best way to support people in this situation.

In a study covering 250 people diagnosed with cancer, motivation therapy was compared to just telling people to quit smoking. In motivation therapy, the patient got counseling, support and nicotine replacement, while the control group was told to give up smoking and given information leaflets. Even though motivation therapy involved more time, effort and expense, it was not more effective at getting people to quit.

But the study showed how some people were more likely to quit successfully than others. Those whose cancer was smoking-related - such as lung, head and neck, or bladder cancer - were more likely to give up. Counseling people to quit smoking when they have cancer is tricky - for instance, if stress makes them smoke, it would be better to address the causes of the stress first. And some patients believe it is too late to give up once they have cancer. They should be informed that, in fact, quitting smoking may improve the outcome of the disease, even after it has been diagnosed.


'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. ZYBAN, The smoking cessation drug marked for its adverse reactions
3. A boost to quit smoking
4. Quitting smoking stops lung decline
5. Passive smoking affects respiratory system
6. Stop smoking and reduce weight
7. Teens listen to parents about smoking
8. Teen smoking declines
9. Cancer patients pursue smoking inspite of risks
10. A new herbal therapy to quit smoking
11. Watching television linked to smoking
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Quit smoking after cancer diagnosis

(Date:7/18/2008)...swire-USNewswire/ -- Two consumer,groups today fil... patent,on human embryonic stem cells held by the ...sumer Watchdog, formerly The Foundation for Taxpay...dation appealed to the U.S. Patent,Office,s Board ...rowed,WARF,s patent after the two groups requested...
(Date:7/18/2008)... within one hour before they undergo spinal surger...after the surgery, suggests a Johns Hopkins study ...Infectious Disease Journal (also available online...s outside of the golden one-hour window were three...ections at the surgery site, researchers report, p...
(Date:7/18/2008)...ptoms, but old drug offers new hope , , ... forward, one step back in the search for treatmen... studies in the July 19 issue of The Lancet , an ...lzheimer,s symptoms. But in a second report, a onc...ion of Alzheimer,s -- even though it cleared demen...
(Date:7/18/2008)...University of Pennsylvania School of Medicine have...ith familial Alzheimer,s disease disrupt the flow ...called PS1 and PS2 (presenilin 1 and 2), interact ... cell compartment. , "The ,calcium dysregulation...lzheimer,s disease has been suggested by previous ...
Breaking Medicine News(10 mins):Health News:Consumer Groups File Appeal on Challenge of Human Stem Cell Patent Held By WARF 2Health News:Averting postsurgical infections in kids: Give antibiotics within hour before first incision 2Health News:Alzheimer's Research Brings Progress, Setbacks 2Health News:Alzheimer's Research Brings Progress, Setbacks 3Health News:Alzheimer's Research Brings Progress, Setbacks 4Health News:Calcium may be the key to understanding Alzheimer's disease 2Health News:Calcium may be the key to understanding Alzheimer's disease 3
...ed by doctors and dentists according to a report r...rowa€?s Furness General Hospital is rated as good ...undly criticised the NHS services in Cumbria. The ... conducted by it is far more wide-ranging and toug...
...e neo-natal intensive care unit of the Rizal Medic...//effect was passed by the Philippine Health Secre...death of seven new born babies. The unfortunate d...rtified by the hospital to have occurred due to un...
...phenomenal rise in sexually transmitted diseases i...f the most common treatable sexually transmitted d...d to have increased four-fold in its incidence rat...ith new cases having been reported in both older a...
...erous, more so because its look and perception spe...lt’ status, and is becoming the life of many parti...that the hookah or the pipe is indeed a wolf in sh...redo, director of the Cancer Genetics and Epidemio...
Other Medicine News:Health News:Sexually Transmitted Diseases Soaring Due To Unsafe Sex 2
(Date:7/16/2008)... Raptor to Support Phase 2a Clinical Trial at UCSD...-- Raptor,Pharmaceuticals Corp. ("Raptor" or the "...ced the execution of a collaboration agreement (th...San Diego ("UCSD") to,include a Phase 2a clinical ... cysteamine bitartrate ("Cysteamine") in adolescen...
(Date:7/15/2008)... Fund Completion of Phase III Trials of Light Infu...tatic Colorectal Cancer and Phase I/II a... BELLEVUE, Wash., July 15 /- Light S...pany developing Light Infusion Therapy(TM),(Litx(T...nounced that it,has raised $40.1 million in a Seri...
(Date:7/15/2008)...Reports 92 Percent Response Rate to Combination Tr...ll/ -- Cephalon, Inc. (Nasdaq:,CEPH) announced tod...in the,Journal of Clinical Oncology, 92 percent of... cell non-Hodgkin,s lymphoma (NHL) responded to tr...e) for Injection plus rituximab.,This combination ...
(Date:7/14/2008)... VIEW, Calif., July 14 /- M...nounced it has initiated its,Phase 3 clinical prog...or,migraine., MAP0004 is orally inhaled and self-...oprietary Tempo(R) inhaler. In the company,s prior...ief in as fast as 10 minutes,with relief sustaine...
Breaking Medicine Technology:Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5Light Sciences Oncology Raises $40.1 Million in Series C Financing 2Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 2Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 3Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 4Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma 5MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 2MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 3MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine 4Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 1Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 2Arobella Medical LLC Launches Qoustic Wound Therapy System 28TM 29 3174 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 1AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 2AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 3AtriCure Announces Initiation of the ABLATE Pivotal Trial to Evaluate the Isolator Synergy 28TM 29 Bipolar Ablation System to Treat Atrial Fibrillatio 3172 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 1American Chemical Societys Weekly PressPac Feb 6 2008 11486 2American Chemical Societys Weekly PressPac Feb 6 2008 11486 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 5American Chemical Societys Weekly PressPac Feb 6 2008 11486 6American Chemical Societys Weekly PressPac Feb 6 2008 11486 7American Chemical Societys Weekly PressPac Feb 6 2008 11486 8American Chemical Societys Weekly PressPac Feb 6 2008 11486 9FindCareHomes com Features New Interactive Tools and Free Services to Simplify the Search for Elder Home Care 11484 1FindCareHomes com Features New Interactive Tools and Free Services to Simplify the Search for Elder Home Care 11484 2
...tober 5, Chiron Corporation notified the CDC that ...available for distribution in the United States fo...s sudden removal of nearly half of the anticipated...e general public have grown increasingly alarmed a...ming epidemic. , ,It remains to be seen if vir...
...ore than 20 years, the PSA test has been widely us...ing. In one of the most dramatic reversals in rece...University School of Medicine and findings by othe...edure in grave doubt. , ,Indeed, The PSA era i...D, professor of urology and lead author of the stu...
Other Medicine Technology:Rapid Flu Tests May Prove Especially Helpful This Season 2Rapid Flu Tests May Prove Especially Helpful This Season 3PSA TestingHow Much is Too Much? 2PSA TestingHow Much is Too Much? 3
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: